Advanced Techniques in Biology & Medicine
Open Access

How Anosmia Related to SARS-CoV-2 Pandemic?

Stella Fletcher^{* *}Correspondence: Stella Fletcher, Department of Biochemistry, Towson University, Maryland, USA, Email:

Author info »

About the Study

One of the symptom most commonly reported in COVID-19 is anosmia. Anosmia is also called as partial or complete loss of the sense of smell. In anosmia, sensory neurons play a major role and these are not among the weak cell type. A study says that olfactory cell types are exposed to infections which are caused by the novel coronavirus. Anosmia is a neurological side effect and one of the most usually found symptoms of COVID-19. Studies predict that some more symptoms like fever and cough are also observed in this disease. However the basic systems for loss of smell in patients with COVID-19 have been seen.

Presently, a worldwide group of researchers recognized that the olfactory cell types generally at risk against contamination by SARS-CoV-2, the virus that causes COVID-19. Shockingly, sensory neurons that distinguish and send the sense of smell to the brain are not among the weak cell types.

The research group observed that olfactory sensory neurons don't communicate the gene that encodes the ACE2 receptor protein, which SARS-CoV-2 uses to enter human cells. Alternatively, ACE2 is communicated in cells that offer metabolic and structural support to olfactory sensory neurons, just as specific populaces of stem cells and blood vessel cells.

The discoveries recommend that contamination of noneuronal cell types might be liable for anosmia in COVID-19 patients and assist with illuminating endeavour’s to all the more likely comprehend the movement of the infection.

Our findings demonstrate that the novel coronavirus changes the sense of smell in patients not by infecting neurons however by infecting the function of supporting cells. This infers that in most cases, SARS-CoV-2 disease is probably not going to forever damage olfactory neural circuits and lead to persistent anosmia, a condition that is related with an assortment of mental and social health problems, especially depression and anxiety.

Once the contamination clears, olfactory neurons don't seem to be replaced or modified without any preparation. However, we need more information and a better comprehension of the basic mechanisms to affirm this conclusion.

Identifying weakness

To our better understand how sense of smell is adjusted in COVID-19 patients by pinpointing cell types generally defenceless against SARS-CoV-2 infection. They started by examining existing single-cell sequencing datasets that altogether classified the genes communicated by a huge number of individual cells in the upper nasal cavities of human, mice and non-human primates.

The researchers focused on the gene ACE2, generally found in cells of the human respiratory tract, which encodes the principle receptor protein that SARS-CoV-2 focuses to gain entry into human cells. They likewise checked out another gene, TMPRSS2, which encodes an enzyme thought to be significant for SARS-CoV-2 entry into the cell.

Here both ACE2 and TMPRSS2 are communicated by cells in the olfactory epithelium, a specific tissue in the top of the nasal cavity liable for odour identification that houses olfactory sensory neurons and an assortment of supporting cells. Neither gene was communicated by olfactory sensory neurons. Conversely, these neurons did communicate genes related with the capacity of other coronaviruses to enter cells.

The researchers observed that two explicit cell types in the olfactory epithelium communicated ACE2 at comparative levels to what in particular has been observed in cells of the lower respiratory tract, the most widely recognized targets of SARSCoV- 2, recommending a weakness to infection.

These included sustentacular cells, which fold over sensory neurons and are thought to offer structural and metabolic help, and basal cells, which act as stem cells that recover the olfactory epithelium after harm. The presence of proteins encoded by the two genes in these cells was affirmed by immunostaining.

In addition, the researchers observed that olfactory epithelium stem cells communicated ACE2 protein at higher levels after falsely initiated harm, contrasted and resting stem cells. This might propose additional SARS-CoV-2 weakness, however it stays unclear whether or how this is vital to the clinical course of anosmia in patients with COVID-19.

Hints for anosmia

Together, this information recommend that COVID-19-related anosmia might emerge from a temporary loss of function of supporting cells in the olfactory epithelium, which indirectly makes changes to olfactory sensory neurons.

Sustentacular cells have generally been ignored, and it seems as though we want to focus on them, like how we have a developing enthusiasm for the critical role that glial cells play in the brain.The findings likewise offer captivating hints into COVID-19-related neurological issues. The perceptions are predictable with hypotheses that SARS-CoV-2 doesn't contaminate neurons but may rather slow down brain function by affecting vascular cells in the nervous system. Therefore, the results presently assist with speeding up endeavour’s to all the more likely comprehend smell loss in patients with COVID-19, which could in turn prompt treatments for anosmia and the further development of smell-based diagnostics for the infection. Anosmia appears to be a peculiar occurrence, however it very well being obliterating for the small fraction of individuals.